Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system

Back

EHRA Premium Access

Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system

Session: What is new on stroke prevention

Topic: Oral Anticoagulation

Speaker: Miss L. Knaepen (Hasselt, BE)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Miss Lieselotte Knaepen

Hasselt University, Hasselt (Belgium)

0 follower

5 more presentations in this session

Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry

Speaker: Doctor M. Gawalko (Maastricht, NL)

Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results

Speaker: Doctor B. Ratajczak-Tretel (Sarpsborg, NO)

Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study

Speaker: Doctor P. Rasmussen (Copenhagen, DK)

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

Speaker: Professor J. Moser (Hamburg, DE)

Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring

Speaker: Mr L. Xing (Copenhagen, DK)

Access the full session

What is new on stroke prevention

Speakers: Miss L. Knaepen, Doctor M. Gawalko, Doctor B. Ratajczak-Tretel, Doctor P. Rasmussen, Professor J. Moser...

Access

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources